Better Quality of Life for People Living with Diabetes Through Validated Innovative Artificial Intelligence Applications

About Melissa

MELISSA aims to innovate diabetes treatment and care for people with insulin-treated diabetes through the development of a clinically validated, efficient and cost-effective Artificial Intelligence-based digital diabetes management solution. This will contribute to every person with insulin-treated diabetes receiving tailored treatment and care according to their individual needs, habits and evolution resulting in a better quality of life.

Start Date
1 June 2022

Duration
4 Years

Budget
approx. 8 Mil. €

12 Partners
7 Countries

Photo of Bastiaan de Galan, MELISSA Coordinator

“Now is the time that we combine forces to relieve people with diabetes on insulin from the burden of managing daily blood glucose highs and lows.”

Bastiaan de Galan, MELISSA Coordinator
Universiteit Maastricht, The Netherlands

Photo of Stephan Proennecke, Project Manager & Director

“A unique opportunity to offer a validated solution for personalized treatment to all patients who do not have the privilege to be equipped with a closed loop.”

Stephan Proennecke, Project Manager & Director
Industrialization at Debiotech S.A., Switzerland

Photo of Prof. Dr Stavroula Mougiakakou, AI in Health and Nutrition Laboratory

“Transparent, trustworthy, validated, and unbiased AI tools have the potential to transform and revolutionise diabetes management.”

Prof. Dr Stavroula Mougiakakou, AI in Health and Nutrition Laboratory
ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland